https://www.selleckchem.com/pr....oducts/salvianolic-a
01-1.41; P=.04 and MV reoperation (10-year actuarial estimates 8.9% vs 0.93%; subdistribution hazard ratio, 4.56; 95% confidence interval, 1.71-12.17; P.01) were observed in the bioprosthetic valve group. Furthermore, the relative mortality benefit associated with mechanical valves was more apparent in younger patients and the beneficial effect persisted until approximately 65years of age. In the patients with RHD who underwent MV replacement, mechanical valves were associated with more favorable long-term outcomes in p
Tycka om
Kommentar
Dela med sig
